Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy / Peeters, M; Siena, S; Van Cutsem, E; Sobrero, A; Hendlisz, A; Cascinu, Stefano; Kalofonos, H; Devercelli, G; Wolf, M; Amado, Rg. - In: CANCER. - ISSN 0008-543X. - Apr 1 2009:(2009), pp. 1544-1554.
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy
CASCINU, Stefano;
2009-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
